Many nations that have ordered CoronaVac are relatively poor, desperate to halt the pandemic and protect their population.
Turkey, which also helped carry out CoronaVac's Phase 3 tests, said the vaccine had shown the effectiveness of 91.25 percent in its trials.
Turkey's health minister Fahrettin Koca said the vaccine will be administered in two doses per person and is expecting delivery of at least 10 million doses in December
Coronavirus vaccine: Lancet study suggests Sinovac candidate is safe and effective in phase I and II trials
CoronaVac is an inactivated vaccine (vaccine that contains a virus unable to cause disease) that had earlier shown positive results in mice, primates and rats by producing neutralising antibodies against SARS-CoV-2